Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study
Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the bes...
Gespeichert in:
Veröffentlicht in: | Prostate cancer and prostatic diseases 2003-12, Vol.6 (4), p.311-314 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 314 |
---|---|
container_issue | 4 |
container_start_page | 311 |
container_title | Prostate cancer and prostatic diseases |
container_volume | 6 |
creator | Ozveri, H Cevik, I Dillioglugil, O Akdaş, A |
description | Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm
3
(5 cm
3
each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better (
P
=0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time. |
doi_str_mv | 10.1038/sj.pcan.4500669 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2645319337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A189222540</galeid><sourcerecordid>A189222540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</originalsourceid><addsrcrecordid>eNp1kk1r3DAQhk1oSdIk596KaKE3b_Qtu7cQkrYQ6CU9C600ysrYkmvZgf331XYXNoEGHSRGz_tqZjRV9ZHgFcGsuc7darQmrrjAWMr2pDonXMlaSNy8K2cmRa0aQc-qDzl3GOOWtPi0OiNcSsYVO6-Gx8nEPIGdTY9GmMI4pTybOVjUB5esCRFQiF0BQorIRMjzBnIwyKcJzS_FeyGgdUhj3n5D5l9o3CmfAeV5cdvL6r03fYarw35R_b6_e7z9UT_8-v7z9uahtrxRc91iBmvBnKOqJa6Rlq5BttTbBpTzXIKzRFrpGCdeEK-YJd5YBURR5Rpq2UX1Ze9bMvizlJR1l5Yplic1lVww0jKmCvX5TYq2WAjO5NHqyfSgQ_SpFG2HkK2-IU1LKRUcF2r1H6osB0OwKYIPJf5K8PWFYAOmnzc59cuuy_k1eL0HbWlm6bXX4xQGM201wXo3Azp3ejcD-jADRfHpUNayHsAd-cOnFwDvgVyu4hNMx7rf8vwLCVO-TQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229055436</pqid></control><display><type>article</type><title>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ozveri, H ; Cevik, I ; Dillioglugil, O ; Akdaş, A</creator><creatorcontrib>Ozveri, H ; Cevik, I ; Dillioglugil, O ; Akdaş, A</creatorcontrib><description>Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm
3
(5 cm
3
each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better (
P
=0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time.</description><identifier>ISSN: 1365-7852</identifier><identifier>EISSN: 1476-5608</identifier><identifier>DOI: 10.1038/sj.pcan.4500669</identifier><identifier>PMID: 14663473</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Aged ; Aged, 80 and over ; Anesthesia ; Anesthesia, Local - adverse effects ; Anesthetics ; Antigens ; Biomedical and Life Sciences ; Biomedicine ; Biopsy ; Biopsy - methods ; Cancer Research ; Care and treatment ; Case-Control Studies ; Complications ; Complications and side effects ; Diagnosis ; Dosage and administration ; Drug therapy ; Humans ; Injection ; Lidocaine ; Lidocaine - administration & dosage ; Lidocaine - adverse effects ; Lidocaine - therapeutic use ; Male ; Middle Aged ; Nerves ; original-article ; Pain ; Pain - drug therapy ; Pain management ; Pain Measurement ; Pain, Postoperative ; Patients ; Prospective Studies ; Prostate ; Prostate cancer ; Prostate-specific antigen ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - diagnostic imaging ; Rectum - diagnostic imaging ; Statistical analysis ; Ultrasonography</subject><ispartof>Prostate cancer and prostatic diseases, 2003-12, Vol.6 (4), p.311-314</ispartof><rights>Springer Nature Limited 2003</rights><rights>COPYRIGHT 2003 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Dec 2003</rights><rights>Nature Publishing Group 2003.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</citedby><cites>FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.pcan.4500669$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.pcan.4500669$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14663473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozveri, H</creatorcontrib><creatorcontrib>Cevik, I</creatorcontrib><creatorcontrib>Dillioglugil, O</creatorcontrib><creatorcontrib>Akdaş, A</creatorcontrib><title>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</title><title>Prostate cancer and prostatic diseases</title><addtitle>Prostate Cancer Prostatic Dis</addtitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><description>Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm
3
(5 cm
3
each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better (
P
=0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia</subject><subject>Anesthesia, Local - adverse effects</subject><subject>Anesthetics</subject><subject>Antigens</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biopsy</subject><subject>Biopsy - methods</subject><subject>Cancer Research</subject><subject>Care and treatment</subject><subject>Case-Control Studies</subject><subject>Complications</subject><subject>Complications and side effects</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Humans</subject><subject>Injection</subject><subject>Lidocaine</subject><subject>Lidocaine - administration & dosage</subject><subject>Lidocaine - adverse effects</subject><subject>Lidocaine - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nerves</subject><subject>original-article</subject><subject>Pain</subject><subject>Pain - drug therapy</subject><subject>Pain management</subject><subject>Pain Measurement</subject><subject>Pain, Postoperative</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>Prostate-specific antigen</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - diagnostic imaging</subject><subject>Rectum - diagnostic imaging</subject><subject>Statistical analysis</subject><subject>Ultrasonography</subject><issn>1365-7852</issn><issn>1476-5608</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kk1r3DAQhk1oSdIk596KaKE3b_Qtu7cQkrYQ6CU9C600ysrYkmvZgf331XYXNoEGHSRGz_tqZjRV9ZHgFcGsuc7darQmrrjAWMr2pDonXMlaSNy8K2cmRa0aQc-qDzl3GOOWtPi0OiNcSsYVO6-Gx8nEPIGdTY9GmMI4pTybOVjUB5esCRFQiF0BQorIRMjzBnIwyKcJzS_FeyGgdUhj3n5D5l9o3CmfAeV5cdvL6r03fYarw35R_b6_e7z9UT_8-v7z9uahtrxRc91iBmvBnKOqJa6Rlq5BttTbBpTzXIKzRFrpGCdeEK-YJd5YBURR5Rpq2UX1Ze9bMvizlJR1l5Yplic1lVww0jKmCvX5TYq2WAjO5NHqyfSgQ_SpFG2HkK2-IU1LKRUcF2r1H6osB0OwKYIPJf5K8PWFYAOmnzc59cuuy_k1eL0HbWlm6bXX4xQGM201wXo3Azp3ejcD-jADRfHpUNayHsAd-cOnFwDvgVyu4hNMx7rf8vwLCVO-TQ</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Ozveri, H</creator><creator>Cevik, I</creator><creator>Dillioglugil, O</creator><creator>Akdaş, A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20031201</creationdate><title>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</title><author>Ozveri, H ; Cevik, I ; Dillioglugil, O ; Akdaş, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia</topic><topic>Anesthesia, Local - adverse effects</topic><topic>Anesthetics</topic><topic>Antigens</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biopsy</topic><topic>Biopsy - methods</topic><topic>Cancer Research</topic><topic>Care and treatment</topic><topic>Case-Control Studies</topic><topic>Complications</topic><topic>Complications and side effects</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Humans</topic><topic>Injection</topic><topic>Lidocaine</topic><topic>Lidocaine - administration & dosage</topic><topic>Lidocaine - adverse effects</topic><topic>Lidocaine - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nerves</topic><topic>original-article</topic><topic>Pain</topic><topic>Pain - drug therapy</topic><topic>Pain management</topic><topic>Pain Measurement</topic><topic>Pain, Postoperative</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>Prostate-specific antigen</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - diagnostic imaging</topic><topic>Rectum - diagnostic imaging</topic><topic>Statistical analysis</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozveri, H</creatorcontrib><creatorcontrib>Cevik, I</creatorcontrib><creatorcontrib>Dillioglugil, O</creatorcontrib><creatorcontrib>Akdaş, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Prostate cancer and prostatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozveri, H</au><au>Cevik, I</au><au>Dillioglugil, O</au><au>Akdaş, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</atitle><jtitle>Prostate cancer and prostatic diseases</jtitle><stitle>Prostate Cancer Prostatic Dis</stitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>6</volume><issue>4</issue><spage>311</spage><epage>314</epage><pages>311-314</pages><issn>1365-7852</issn><eissn>1476-5608</eissn><abstract>Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm
3
(5 cm
3
each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better (
P
=0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>14663473</pmid><doi>10.1038/sj.pcan.4500669</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1365-7852 |
ispartof | Prostate cancer and prostatic diseases, 2003-12, Vol.6 (4), p.311-314 |
issn | 1365-7852 1476-5608 |
language | eng |
recordid | cdi_proquest_journals_2645319337 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Aged Aged, 80 and over Anesthesia Anesthesia, Local - adverse effects Anesthetics Antigens Biomedical and Life Sciences Biomedicine Biopsy Biopsy - methods Cancer Research Care and treatment Case-Control Studies Complications Complications and side effects Diagnosis Dosage and administration Drug therapy Humans Injection Lidocaine Lidocaine - administration & dosage Lidocaine - adverse effects Lidocaine - therapeutic use Male Middle Aged Nerves original-article Pain Pain - drug therapy Pain management Pain Measurement Pain, Postoperative Patients Prospective Studies Prostate Prostate cancer Prostate-specific antigen Prostatic Neoplasms - diagnosis Prostatic Neoplasms - diagnostic imaging Rectum - diagnostic imaging Statistical analysis Ultrasonography |
title | Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A00%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transrectal%20periprostatic%20lidocaine%20injection%20anesthesia%20for%20transrectal%20prostate%20biopsy:%20a%20prospective%20study&rft.jtitle=Prostate%20cancer%20and%20prostatic%20diseases&rft.au=Ozveri,%20H&rft.date=2003-12-01&rft.volume=6&rft.issue=4&rft.spage=311&rft.epage=314&rft.pages=311-314&rft.issn=1365-7852&rft.eissn=1476-5608&rft_id=info:doi/10.1038/sj.pcan.4500669&rft_dat=%3Cgale_proqu%3EA189222540%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229055436&rft_id=info:pmid/14663473&rft_galeid=A189222540&rfr_iscdi=true |